Clinical trials suggest it can lead to a weight reduction of 15-20% over a year, offering potentially better results than Ozempic
Homeostatic model assessment (HOMA) 2-B provides a validated tool to assess beta-cell function
In addition, through modulation of cardiolipin redox state, mGSH can also regulate OMM permeabilization via MPT and the release of apoptogenic proteins
Baran Dilaver Timing is a great question

Rybelsus (semaglutide) is a GLP-1 receptor agonist that does not cause physical dependence or withdrawal symptoms when stopped abruptly Discontinuing Rybelsus leads to rising blood glucose levels, increased appetite, and potential weight regain as the medication's effects diminish over 45 weeks Stopping without medical supervision and an alternative diabetes management plan increases risk of poor glycaemic control and long-term complications NICE and MHRA guidance recommend discussing any medication changes with your healthcare team to ensure continuity of diabetes management Safe discontinuation requires monitoring blood glucose levels, implementing lifestyle strategies, and potentially starting alternative medications under medical supervision Table of Contents What Happens When You Stop Taking Rybelsus Suddenly Rybelsus (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve glycaemic control in adults with type 2 diabetes mellitus

One analysis of patients from insulin to an insulin/GLP-1RA fixed combination identified candidates that would benefit from such a switch